Differential Toxicities of Tyrosine Kinase Inhibitors in the Management of Metastatic Lung Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Differential Toxicities of Tyrosine Kinase Inhibitors in the Management of Metastatic Lung Cancer ; volume:38 ; number:01 ; year:2017 ; pages:15-17
Indian journal of medical & paediatric oncology ; 38, Heft 01 (2017), 15-17
- Beteiligte Personen und Organisationen
-
Udupa, Karthik S.
Rajendranath, Rejiv
Sagar, Tenali
Thomas, Joseph
- DOI
-
10.4103/0971-5851.203502
- URN
-
urn:nbn:de:101:1-2021082711502834365623
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Udupa, Karthik S.
- Rajendranath, Rejiv
- Sagar, Tenali
- Thomas, Joseph
Ähnliche Objekte (12)
Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma
Differential toxicities of insecticides and halogenated aromatics
Co-administration of tyrosine kinase inhibitors with rottlerin in metastatic prostate cancer cells
Editorial: Targeting bruton tyrosine kinase
Differential toxicities of fine particulate matters from various sources
Comparative genomics of Cylindrospermopsis raciborskii strains with differential toxicities
Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Their Use and Differential Features
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
Newer Tyrosine Kinase Inhibitors for CML
Economic burden of toxicities associated with treating metastatic melanoma in eight countries
Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors
Second-generation inhibitors of Bruton tyrosine kinase
Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma
Differential toxicities of insecticides and halogenated aromatics
Co-administration of tyrosine kinase inhibitors with rottlerin in metastatic prostate cancer cells
Editorial: Targeting bruton tyrosine kinase
Differential toxicities of fine particulate matters from various sources
Comparative genomics of Cylindrospermopsis raciborskii strains with differential toxicities
Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Their Use and Differential Features
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
Newer Tyrosine Kinase Inhibitors for CML
Economic burden of toxicities associated with treating metastatic melanoma in eight countries
Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors
Second-generation inhibitors of Bruton tyrosine kinase
Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma
Differential toxicities of insecticides and halogenated aromatics
Co-administration of tyrosine kinase inhibitors with rottlerin in metastatic prostate cancer cells
Editorial: Targeting bruton tyrosine kinase
Differential toxicities of fine particulate matters from various sources
Comparative genomics of Cylindrospermopsis raciborskii strains with differential toxicities
Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies: Their Use and Differential Features
Protein tyrosine kinase 2b inhibition reverts niche-associated resistance to tyrosine kinase inhibitors in AML
Newer Tyrosine Kinase Inhibitors for CML
Economic burden of toxicities associated with treating metastatic melanoma in eight countries
Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors